In:
Acta Ophthalmologica, Wiley, Vol. 87, No. 3 ( 2009-05), p. 349-352
Abstract:
Purpose: To evaluate the therapeutic effect of intravitreal bevacizumab in patients with uveitis‐associated choroidal/retinal neovascularization. Methods: Two female patients (40 years, 15 years) with posterior uveitis, (one presumed ocular sarcoidosis, one lupus) were evaluated for neovascularization of the posterior segment. Both patients were given a single dose of 1.25 mg intravitreal bevacizumab. Results: Significant anatomical and functional recovery was evident in both patients within a few weeks. Conclusion: In selected uveitic patients, bevacizumab may be an option for managing neovascularization.
Type of Medium:
Online Resource
ISSN:
1755-375X
,
1755-3768
DOI:
10.1111/aos.2009.87.issue-3
DOI:
10.1111/j.1755-3768.2008.01208.x
Language:
English
Publisher:
Wiley
Publication Date:
2009
detail.hit.zdb_id:
2466981-7
Permalink